Lanreotide
Lanreotide (BIM 23014) is a somatostatin analogue with antineoplastic activity. Lanreotide can be used for the research of carcinoid syndrome[1][2].
Product Specifications
CAS Number
108736-35-2
Product Name Alternative
BIM 23014
UNSPSC
12352209
Hazard Statement
H302, H312, H332
Target
Somatostatin Receptor
Type
Peptides
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Cancer; Endocrinology
Assay Protocol
https://www.medchemexpress.com/lanreotide.html
Purity
98.86
Solubility
DMSO : 100 mg/mL (ultrasonic) |H2O : 25 mg/mL
Smiles
O=C([C@@H](NC([C@@](CSSC[C@@H](C(N[C@H](C(N)=O)[C@H](O)C)=O)NC([C@H](C(C)C)NC([C@@](CCCCN)([H])NC1=O)=O)=O)([H])NC([C@H](N)CC2=CC3=CC=CC=C3C=C2)=O)=O)CC4=CC=C(O)C=C4)N[C@@H]1CC5=CNC6=C5C=CC=C6
Molecular Formula
C54H69N11O10S2
Molecular Weight
1096.32
Precautions
H302, H312, H332
References & Citations
[1]Ning S, et al. Lanreotide promotes apoptosis and is not radioprotective in GH3 cells.Endocr Relat Cancer. 2009 Sep;16 (3) :1045-55.|[2]Florio T, et al. Characterization of the intracellular mechanisms mediating somatostatin and lanreotide inhibition of DNA synthesis and growth hormone release from dispersed human GH-secreting pituitary adenoma cells in vitro.Clin Endocrinol (Oxf) . 2003 Jul;59 (1) :115-28.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-T344170-25MG 25 mg
2,7-Thianthrenedicarboxylic Acid(contain ~5% 2,8-isomer)
Sign In for Pricing
View Details 
PKSH033312-01 10 µg
Recombinant Human GOLPH2/GOLM1 Protein (aa 36-401, His Tag)
Sign In for Pricing
View Details